Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness

Ena Wang, Lance D. Miller, Galen A. Ohnmacht, Simone Mocellin, Ainhoa Perez-Diez, David Petersen, Yingdong Zhao, Richard Simon, John I. Powell, Esther Asaki, H. Richard Alexander, Paul H. Duray, Meenhard Herlyn, Nicholas P. Restifo, Edison T. Liu, Steven A. Rosenberg, Francesco M. Marincola

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melanoma metastases from 25 patients undergoing immunotherapy for hybridization to a 6108-gene human cDNA chip. By prospectively following the history of the lesions, we could correlate transcript patterns with clinical outcome. Cluster analysis revealed a tight relationship among autologous synchronously sampled tumors compared with unrelated lesions (average Pearson's r = 0.83 and 0.7, respectively, P < 0.0003). As reported previously, two subgroups of metastatic melanoma lesions were identified that, however, had no predictive correlation with clinical outcome. Ranking of gene expression data from pretreatment samples identified ∼30 genes predictive of clinical response (P < 0.001). Analysis of their annotations denoted that approximately half of them were related to T-cell regulation, suggesting that immune responsiveness might be predetermined by a tumor microenvironment conducive to immune recognition.

Original languageEnglish
Pages (from-to)3581-3586
Number of pages6
JournalCancer Research
Volume62
Issue number13
Publication statusPublished - 1 Jul 2002
Externally publishedYes

Fingerprint

Melanoma
Neoplasm Metastasis
Tumor Microenvironment
Fine Needle Biopsy
Immunotherapy
Genes
Cluster Analysis
Complementary DNA
History
RNA
T-Lymphocytes
Gene Expression
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Wang, E., Miller, L. D., Ohnmacht, G. A., Mocellin, S., Perez-Diez, A., Petersen, D., ... Marincola, F. M. (2002). Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Research, 62(13), 3581-3586.

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. / Wang, Ena; Miller, Lance D.; Ohnmacht, Galen A.; Mocellin, Simone; Perez-Diez, Ainhoa; Petersen, David; Zhao, Yingdong; Simon, Richard; Powell, John I.; Asaki, Esther; Alexander, H. Richard; Duray, Paul H.; Herlyn, Meenhard; Restifo, Nicholas P.; Liu, Edison T.; Rosenberg, Steven A.; Marincola, Francesco M.

In: Cancer Research, Vol. 62, No. 13, 01.07.2002, p. 3581-3586.

Research output: Contribution to journalArticle

Wang, E, Miller, LD, Ohnmacht, GA, Mocellin, S, Perez-Diez, A, Petersen, D, Zhao, Y, Simon, R, Powell, JI, Asaki, E, Alexander, HR, Duray, PH, Herlyn, M, Restifo, NP, Liu, ET, Rosenberg, SA & Marincola, FM 2002, 'Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness', Cancer Research, vol. 62, no. 13, pp. 3581-3586.
Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D et al. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Research. 2002 Jul 1;62(13):3581-3586.
Wang, Ena ; Miller, Lance D. ; Ohnmacht, Galen A. ; Mocellin, Simone ; Perez-Diez, Ainhoa ; Petersen, David ; Zhao, Yingdong ; Simon, Richard ; Powell, John I. ; Asaki, Esther ; Alexander, H. Richard ; Duray, Paul H. ; Herlyn, Meenhard ; Restifo, Nicholas P. ; Liu, Edison T. ; Rosenberg, Steven A. ; Marincola, Francesco M. / Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. In: Cancer Research. 2002 ; Vol. 62, No. 13. pp. 3581-3586.
@article{b10966333e854c12be1365599b19c2d7,
title = "Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness",
abstract = "We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melanoma metastases from 25 patients undergoing immunotherapy for hybridization to a 6108-gene human cDNA chip. By prospectively following the history of the lesions, we could correlate transcript patterns with clinical outcome. Cluster analysis revealed a tight relationship among autologous synchronously sampled tumors compared with unrelated lesions (average Pearson's r = 0.83 and 0.7, respectively, P < 0.0003). As reported previously, two subgroups of metastatic melanoma lesions were identified that, however, had no predictive correlation with clinical outcome. Ranking of gene expression data from pretreatment samples identified ∼30 genes predictive of clinical response (P < 0.001). Analysis of their annotations denoted that approximately half of them were related to T-cell regulation, suggesting that immune responsiveness might be predetermined by a tumor microenvironment conducive to immune recognition.",
author = "Ena Wang and Miller, {Lance D.} and Ohnmacht, {Galen A.} and Simone Mocellin and Ainhoa Perez-Diez and David Petersen and Yingdong Zhao and Richard Simon and Powell, {John I.} and Esther Asaki and Alexander, {H. Richard} and Duray, {Paul H.} and Meenhard Herlyn and Restifo, {Nicholas P.} and Liu, {Edison T.} and Rosenberg, {Steven A.} and Marincola, {Francesco M.}",
year = "2002",
month = "7",
day = "1",
language = "English",
volume = "62",
pages = "3581--3586",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness

AU - Wang, Ena

AU - Miller, Lance D.

AU - Ohnmacht, Galen A.

AU - Mocellin, Simone

AU - Perez-Diez, Ainhoa

AU - Petersen, David

AU - Zhao, Yingdong

AU - Simon, Richard

AU - Powell, John I.

AU - Asaki, Esther

AU - Alexander, H. Richard

AU - Duray, Paul H.

AU - Herlyn, Meenhard

AU - Restifo, Nicholas P.

AU - Liu, Edison T.

AU - Rosenberg, Steven A.

AU - Marincola, Francesco M.

PY - 2002/7/1

Y1 - 2002/7/1

N2 - We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melanoma metastases from 25 patients undergoing immunotherapy for hybridization to a 6108-gene human cDNA chip. By prospectively following the history of the lesions, we could correlate transcript patterns with clinical outcome. Cluster analysis revealed a tight relationship among autologous synchronously sampled tumors compared with unrelated lesions (average Pearson's r = 0.83 and 0.7, respectively, P < 0.0003). As reported previously, two subgroups of metastatic melanoma lesions were identified that, however, had no predictive correlation with clinical outcome. Ranking of gene expression data from pretreatment samples identified ∼30 genes predictive of clinical response (P < 0.001). Analysis of their annotations denoted that approximately half of them were related to T-cell regulation, suggesting that immune responsiveness might be predetermined by a tumor microenvironment conducive to immune recognition.

AB - We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melanoma metastases from 25 patients undergoing immunotherapy for hybridization to a 6108-gene human cDNA chip. By prospectively following the history of the lesions, we could correlate transcript patterns with clinical outcome. Cluster analysis revealed a tight relationship among autologous synchronously sampled tumors compared with unrelated lesions (average Pearson's r = 0.83 and 0.7, respectively, P < 0.0003). As reported previously, two subgroups of metastatic melanoma lesions were identified that, however, had no predictive correlation with clinical outcome. Ranking of gene expression data from pretreatment samples identified ∼30 genes predictive of clinical response (P < 0.001). Analysis of their annotations denoted that approximately half of them were related to T-cell regulation, suggesting that immune responsiveness might be predetermined by a tumor microenvironment conducive to immune recognition.

UR - http://www.scopus.com/inward/record.url?scp=0036645090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036645090&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 3581

EP - 3586

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 13

ER -